The Latest Breaking News from Moderna

Moderna stock toppled Thursday after missing guidance expectations by at least $2 billion as waning Covid shots champ at sales.

The Dow Jones chased tech stocks higher Thursday after key economic data, Nvidia surged on earnings results, while Lucid plunged 14%.

Moderna stock toppled Friday on mixed results for its flu shot — a rival to experimental vaccines from BioNTech, CureVac and Sanofi.

One of the largest studies conducted on COVID immunity finds that previous infections provide protection for as long as vaccination, but experts caution vaccines are still the safer option.

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

Moderna said Wednesday it wouldn’t raise the price of its COVID-19 vaccine after a public outcry.

The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.

A Relative Strength Rating upgrade for Moderna shows improving technical performance. Will it continue?

After railing at the injustices of U.S. health care for decades, Sen. Bernie Sanders in January became the new chairman of the Senate Health, Education, Labor & Pensions Committee. The job gives the health care industry’s biggest Washington nemesis an unprecedented opportunity to shape health care reform in Congress. But…